富士製薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/10/08 | 1,321 | 1,337 | 1,316 | 1,322 | -13 | -1% | 93,000 |
| 2024/10/07 | 1,352 | 1,353 | 1,325 | 1,335 | -4 | -0.3% | 85,300 |
| 2024/10/04 | 1,341 | 1,351 | 1,332 | 1,339 | +10 | +0.8% | 115,600 |
| 2024/10/03 | 1,310 | 1,337 | 1,309 | 1,329 | +58 | +4.6% | 194,500 |
| 2024/10/02 | 1,294 | 1,301 | 1,268 | 1,271 | -28 | -2.2% | 48,700 |
| 2024/10/01 | 1,277 | 1,308 | 1,277 | 1,299 | +26 | +2% | 78,200 |
| 2024/09/30 | 1,267 | 1,287 | 1,260 | 1,273 | -15 | -1.2% | 128,200 |
| 2024/09/27 | 1,286 | 1,292 | 1,268 | 1,288 | -25 | -1.9% | 103,400 |
| 2024/09/26 | 1,298 | 1,313 | 1,293 | 1,313 | +21 | +1.6% | 118,000 |
| 2024/09/25 | 1,302 | 1,303 | 1,275 | 1,292 | +8 | +0.6% | 82,100 |
| 2024/09/24 | 1,269 | 1,303 | 1,268 | 1,284 | +21 | +1.7% | 124,400 |
| 2024/09/20 | 1,277 | 1,282 | 1,259 | 1,263 | -6 | -0.5% | 111,900 |
| 2024/09/19 | 1,249 | 1,275 | 1,249 | 1,269 | +37 | +3% | 72,100 |
| 2024/09/18 | 1,232 | 1,246 | 1,221 | 1,232 | +4 | +0.3% | 47,900 |
| 2024/09/17 | 1,243 | 1,252 | 1,212 | 1,228 | -9 | -0.7% | 62,400 |
| 2024/09/13 | 1,246 | 1,253 | 1,232 | 1,237 | -15 | -1.2% | 53,600 |
| 2024/09/12 | 1,249 | 1,270 | 1,242 | 1,252 | +11 | +0.9% | 61,000 |
| 2024/09/11 | 1,265 | 1,269 | 1,234 | 1,241 | -29 | -2.3% | 54,900 |
| 2024/09/10 | 1,289 | 1,289 | 1,270 | 1,270 | -10 | -0.8% | 35,100 |
| 2024/09/09 | 1,239 | 1,284 | 1,238 | 1,280 | -10 | -0.8% | 85,700 |
| 2024/09/06 | 1,317 | 1,318 | 1,283 | 1,290 | -24 | -1.8% | 45,500 |
| 2024/09/05 | 1,287 | 1,326 | 1,284 | 1,314 | +13 | +1% | 58,200 |
| 2024/09/04 | 1,317 | 1,327 | 1,298 | 1,301 | -38 | -2.8% | 118,200 |
| 2024/09/03 | 1,336 | 1,343 | 1,330 | 1,339 | +2 | +0.1% | 88,000 |
| 2024/09/02 | 1,351 | 1,363 | 1,334 | 1,337 | -22 | -1.6% | 59,100 |
| 2024/08/30 | 1,343 | 1,359 | 1,335 | 1,359 | +29 | +2.2% | 77,900 |
| 2024/08/29 | 1,343 | 1,352 | 1,326 | 1,330 | -15 | -1.1% | 81,800 |
| 2024/08/28 | 1,358 | 1,358 | 1,336 | 1,345 | -28 | -2% | 61,300 |
| 2024/08/27 | 1,333 | 1,377 | 1,333 | 1,373 | +30 | +2.2% | 79,400 |
| 2024/08/26 | 1,354 | 1,359 | 1,333 | 1,343 | -12 | -0.9% | 82,100 |
| 2024/08/23 | 1,360 | 1,373 | 1,352 | 1,355 | +3 | +0.2% | 64,200 |
| 2024/08/22 | 1,352 | 1,369 | 1,346 | 1,352 | -3 | -0.2% | 77,000 |
| 2024/08/21 | 1,356 | 1,373 | 1,351 | 1,355 | -12 | -0.9% | 79,200 |
| 2024/08/20 | 1,382 | 1,391 | 1,350 | 1,367 | -2 | -0.1% | 181,600 |
| 2024/08/19 | 1,383 | 1,406 | 1,362 | 1,369 | +83 | +6.5% | 562,000 |
| 2024/08/16 | 1,280 | 1,287 | 1,264 | 1,286 | +34 | +2.7% | 81,800 |
| 2024/08/15 | 1,237 | 1,265 | 1,231 | 1,252 | +12 | +1% | 47,600 |
| 2024/08/14 | 1,223 | 1,243 | 1,210 | 1,240 | +18 | +1.5% | 82,900 |
| 2024/08/13 | 1,220 | 1,225 | 1,205 | 1,222 | +9 | +0.7% | 88,300 |
| 2024/08/09 | 1,279 | 1,279 | 1,183 | 1,213 | +23 | +1.9% | 172,000 |
| 2024/08/08 | 1,200 | 1,217 | 1,186 | 1,190 | -12 | -1% | 80,100 |
| 2024/08/07 | 1,161 | 1,237 | 1,161 | 1,202 | -13 | -1.1% | 127,100 |
| 2024/08/06 | 1,183 | 1,226 | 1,155 | 1,215 | +122 | +11.2% | 224,000 |
| 2024/08/05 | 1,178 | 1,214 | 1,089 | 1,093 | -175 | -13.8% | 252,100 |
| 2024/08/02 | 1,300 | 1,306 | 1,268 | 1,268 | -82 | -6.1% | 180,100 |
| 2024/08/01 | 1,402 | 1,402 | 1,349 | 1,350 | -55 | -3.9% | 98,600 |
| 2024/07/31 | 1,375 | 1,405 | 1,366 | 1,405 | +29 | +2.1% | 50,500 |
| 2024/07/30 | 1,392 | 1,392 | 1,369 | 1,376 | -15 | -1.1% | 82,100 |
| 2024/07/29 | 1,388 | 1,402 | 1,386 | 1,391 | +20 | +1.5% | 61,800 |
| 2024/07/26 | 1,383 | 1,395 | 1,371 | 1,371 | -11 | -0.8% | 82,700 |
151～
200
件表示中 / 6958件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 富士製薬 | 128,500円 | +15.7% | +5.3% | 3.54% | 9.29倍 | 0.69倍 |
|
女性医療、急性期医療の２領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
| 生化学 | 63,900円 | -9.6% | -30.2% | 4.69% | 25.83倍 | 0.48倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。２種のヒアルロン酸製剤は科研と参天が販売 |
| ヘリオス | 32,900円 | +150.0% | - | 0.00% | - | 16.18倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ダイト | 205,700円 | +4.5% | -33.7% | 3.40% | 20.56倍 | 0.59倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック（後発医薬品）メーカー向け強い |
| ミズホメディ | 150,100円 | +1.2% | -13.9% | 5.66% | 8.85倍 | 1.65倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
市場注目の銘柄
チャート関連のコラム
